SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-001831
Filing Date
2023-08-14
Accepted
2023-08-14 07:31:22
Documents
48
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bcli-20230630x10q.htm   iXBRL 10-Q 940744
2 EX-31.1 bcli-20230630xex31d1.htm EX-31.1 9475
3 EX-31.2 bcli-20230630xex31d2.htm EX-31.2 9477
4 EX-31.3 bcli-20230630xex31d3.htm EX-31.3 10084
5 EX-32.1 bcli-20230630xex32d1.htm EX-32.1 5629
6 EX-32.2 bcli-20230630xex32d2.htm EX-32.2 6782
7 EX-32.3 bcli-20230630xex32d3.htm EX-32.3 6809
  Complete submission text file 0001410578-23-001831.txt   3128650

Data Files

Seq Description Document Type Size
8 EX-101.SCH bcli-20230630.xsd EX-101.SCH 23568
9 EX-101.CAL bcli-20230630_cal.xml EX-101.CAL 26518
10 EX-101.DEF bcli-20230630_def.xml EX-101.DEF 76852
11 EX-101.LAB bcli-20230630_lab.xml EX-101.LAB 189981
12 EX-101.PRE bcli-20230630_pre.xml EX-101.PRE 149032
42 EXTRACTED XBRL INSTANCE DOCUMENT bcli-20230630x10q_htm.xml XML 329098
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36641 | Film No.: 231166273
SIC: 2836 Biological Products, (No Diagnostic Substances)